Company Performance: Profitability, revenue growth, and debt levels significantly impact investor confidence and the stock price.

Industry Trends: The overall health and growth prospects of the pharmaceutical industry influence valuations.

Regulatory Changes: New regulations regarding drug pricing, approvals, and healthcare policies can affect the company's future earnings.

Market Sentiment: General market conditions, investor risk appetite, and economic outlook play a role in stock valuations.

Competition: The presence of strong competitors and the launch of competing drugs can impact market share and profitability.

Macroeconomic Factors: Interest rates, inflation, and exchange rates can indirectly impact the company's operations and profitability.

Geopolitical Events: Global events, trade wars, and political instability can affect investor sentiment and supply chains.

Product Pipeline: Success in developing and launching new drugs is crucial for future growth and stock appreciation.

Management Effectiveness: Competent leadership and strategic decision-making are important for long-term success and investor confidence.

Analyst Ratings: Investment analyst upgrades or downgrades can influence investor behavior and stock price movements.